XYZAL levocetirizine hydrochloride 5 mg film coated tablet blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

levocetirizine dihydrochloride, Quantity: 5 mg

Verfügbar ab:

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

INN (Internationale Bezeichnung):

levocetirizine dihydrochloride

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 400

Verabreichungsweg:

Oral

Einheiten im Paket:

1, 28, 30, 2, 10, 7

Verschreibungstyp:

(S2) Pharmacy Medicine

Anwendungsgebiete:

Xyzal tablets are indicated for the symptomatic treatment of allergic rhinitis (including persistent allergic rhinitis) and chronic idiopathic urticaria.

Produktbesonderheiten:

Visual Identification: White to off white, oval film-coated tablet with Y logo on one side.; Container Type: Blister Pack; Container Life Time: 5 Years; Container Temperature: Store below 30 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2008-03-06